These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11243687)

  • 21. Comparison of primary vaccination regimes for equine influenza: working towards an evidence-based regime.
    Cullinane A; Gildea S; Weldon E
    Equine Vet J; 2014 Nov; 46(6):669-73. PubMed ID: 24237177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

  • 24. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.
    Wilson WD; Mihalyi JE; Hussey S; Lunn DP
    Equine Vet J; 2001 Nov; 33(7):644-50. PubMed ID: 11770984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
    Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
    Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
    Fougerolle S; Legrand L; Garrett D; Birand I; Foursin M; D'Ablon X; Bayssat P; Newton RJ; Pronost S; Paillot R
    Vaccine; 2016 Jul; 34(33):3787-95. PubMed ID: 27269055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
    Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current perspectives on control of equine influenza.
    Daly JM; Newton JR; Mumford JA
    Vet Res; 2004; 35(4):411-23. PubMed ID: 15236674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An updated equine influenza vaccine and an equine influenza-herpesvirus combination vaccine containing an immunostim adjuvant provoke equal antibody levels in young foals throughout the primary vaccination course.
    Heldens JG; Van de Wouw JC; Van Loon AA
    Vet J; 2002 Nov; 164(3):288-91. PubMed ID: 12505406
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field observations on influenza vaccination among horses in Britain, 1971-1976.
    Powell DG; Burrows R; Spooner P; Mumford J; Thomson G
    Dev Biol Stand; 1977 Jun 1-3; 39():347-52. PubMed ID: 604119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains.
    Ibañez LI; Caldevilla CA; Paredes Rojas Y; Mattion N
    Vaccine; 2018 Mar; 36(12):1592-1598. PubMed ID: 29454522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishing an acceptability threshold for equine influenza vaccines.
    Mumford JA; Wood J
    Dev Biol Stand; 1992; 79():137-46. PubMed ID: 1286748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan.
    Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Matsumura T; Kokado H; Gildea S; Cullinane A
    J Vet Med Sci; 2018 Mar; 80(2):382-386. PubMed ID: 29237998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.